Australia's largest stock trading and investment forum Australia's #1 stock forum

POH

Click for more information

0.00%

0.0¢ progress 2023-2 trust

..remember poh/usda mastitis trials were abandoned due to the...

First 2 Last

Share
Profile

Follow
turps

6,900 Posts.

37

14/02/19

10:55

Post #: 37434015
Share

Originally posted by hottod ↑

Congratulations to Dr Roksan Libinaki, who was granted US Patent 10,188,670 on 29 January. The Composition patent relates to the use of TPM in the treatment of mastitis (animal or human) and covers all routes of administration.

It is the second US patent approval for Roksan in the space of a few months. Last September, her patent relating to the use of TPM in delivering both cosmeceutical and nutraceutical actives was also approved.

Both patents have been assigned to Phosphagenics.

http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=/netahtml/PTO/search-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=phosphagenics.ASNM.&OS=AN/phosphagenics&RS=AN/phosphagenics

https://hotcopper.com.au/threads/an...4501015/page-38?post_id=36229611#.XGPMBTMzaUk

Expand

..remember poh/usda mastitis trials were abandoned due to the gfc ?….an abrupt end to what was to be another multi billion dollar pursuit

unlike the feed trials (whilst good), the mastitis results were outstanding, and it appears the formula has been improved...good luck poh...we're due

POH Price at posting: 0.4¢ Sentiment: Buy Disclosure: Held
15 Upvote

0 Great analysis

Reply

There are more pages in this discussion • 1 more message in this thread...

First 2 Last

Add POH (ASX) to my watchlist

(20min delay)
Last 0.0¢		Change 0.000(0.00%)		Mkt cap ! n/a

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

POH (ASX) Chart

Day chart unavailable